Research results from Baylor College of Medicine update understanding of movement disorders

Pain & Central Nervous System Week via NewsEdge Corporation :

2006 DEC 18 -
www.NewsRx.com
-- New investigation results, "Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus," are detailed in a study published in Movement Disorders. According to recent research from the United States, "We reported a 74-year-old woman with new-onset diabetes mellitus who presented with the sudden onset of mild left hemiparesis and marked left hemichorea-hemiballismus. Brain CT scan and MRI showed T1W, T2W, and DWI lesions in the right putamen and caudate, which have been previously reported in cases of hyperglycemic-induced hemichorea-hemiballismus (HIHH)."

"The patient dramatically responded to tetrabenazine within a day. Subsequent dose reductions lead to a reemergence of symptoms," wrote O. Sitburana and colleagues, Baylor College of Medicine.

The researchers concluded: "Tetrabenazine improves a variety of hyperkinetic movement disorders but, to our knowledge, its use has never been reported for HIHH."

Sitburana and colleagues published their study in Movement Disorders (Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus. Movement Disorders, 2006;21(11):2023-5).

For additional information, contact O. Sitburana, Parkinson's Disease Center and Movement Disorders Clinic, Dept. of Neurology, Baylor College of Medicine, Houston, Texas U.S.

Publisher contact information for the journal Movement Disorders is: Wiley-Liss, Division John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030, USA.

Keywords: United States, Houston, Movement Disorders, Movement Disorder.

This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2006, Pain & Central Nervous System Week via NewsRx.com.

<<Pain & Central Nervous System Week -- 12/15/06>>